SUBSCRIBE
SUBSCRIBE

Novel DPP-4 Drug Works in Renal Impairment

September 24, 2010 | 
1 min read
MPT -- The novel diabetes drug linagliptin (proposed trade name Ondero) may find a niche in treating patients with kidney problems, diabetologists suggested here.